Literature DB >> 19017300

Molecular mechanisms of HLA association with autoimmune diseases.

S Caillat-Zucman1.   

Abstract

The association of human leukocyte antigen (HLA) molecules with many autoimmune diseases has been long known. Yet, the molecular basis for these associations remains unclear for most of these diseases because of the lack of identification of a primary target autoantigen or autoantigens. In two frequent autoimmune disorders, however, celiac disease and type 1 diabetes, recent progress in the identification of immunogenic antigen epitopes and analysis of crystal structure of particular HLA molecules in complex with disease-specific epitopes has allowed for a better understanding of the molecular mechanisms underlying disease association. In this review, these two diseases will be analyzed in detail to show how HLA polymorphisms may directly contribute to susceptibility to, or protection from, disease. Such analyses have significant interest in clinical practice to identify at-risk individuals and elaborate new therapeutic strategies aiming at inhibiting or preventing the autoimmune process.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19017300     DOI: 10.1111/j.1399-0039.2008.01167.x

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN: 0001-2815


  21 in total

Review 1.  Overview of the immune response.

Authors:  David D Chaplin
Journal:  J Allergy Clin Immunol       Date:  2010-02       Impact factor: 10.793

2.  Association of HLA-DQB1 alleles with risk of follicular lymphoma.

Authors:  Nicholas K Akers; John D Curry; Lucia Conde; Paige M Bracci; Martyn T Smith; Christine F Skibola
Journal:  Leuk Lymphoma       Date:  2010-12-06

Review 3.  Revealing the genetic basis of multiple sclerosis: are we there yet?

Authors:  Sergio E Baranzini
Journal:  Curr Opin Genet Dev       Date:  2011-01-17       Impact factor: 5.578

4.  Haplotype-based analysis: a summary of GAW16 Group 4 analysis.

Authors:  Elizabeth Hauser; Nadine Cremer; Rebecca Hein; Harshal Deshmukh
Journal:  Genet Epidemiol       Date:  2009       Impact factor: 2.135

5.  HLA genotyping in pediatric celiac disease patients.

Authors:  Biljana Stanković; Nedeljko Radlović; Zoran Leković; Dragana Ristić; Vladimir Radlović; Gordana Nikčević; Nikola Kotur; Ksenija Vučićević; Tatjana Kostić; Sonja Pavlović; Branka Zukic
Journal:  Bosn J Basic Med Sci       Date:  2014-08-16       Impact factor: 3.363

6.  HLA molecules and nasal carriage of Staphylococcus aureus isolated from dialysis and kidney transplant patients at a hospital in Southern Brazil.

Authors:  Luciana Borges Giarola; Rosiane Ribeiro Dos Santos; João Bedendo; Waldir Veríssimo da Silva Júnior; Sueli Donizete Borelli
Journal:  BMC Res Notes       Date:  2012-02-09

Review 7.  Research progress on Melkersson-Rosenthal syndrome.

Authors:  Wenjing Kuang; Xiaobo Luo; Jiongke Wang; Xin Zeng
Journal:  Zhejiang Da Xue Xue Bao Yi Xue Ban       Date:  2021-04-25

8.  The genetic polymorphisms of HLA are strongly correlated with the disease severity after Hantaan virus infection in the Chinese Han population.

Authors:  Ying Ma; Bin Yuan; Jing Yi; Ran Zhuang; Jiuping Wang; Yun Zhang; Zhuwei Xu; Yusi Zhang; Bei Liu; Chao Wei; Chunmei Zhang; Angang Yang; Boquan Jin
Journal:  Clin Dev Immunol       Date:  2012-10-08

9.  Targeting the immunogenetic diseases with the appropriate HLA molecular typing: critical appraisal on 2666 patients typed in one single centre.

Authors:  M Guarene; C Capittini; A De Silvestri; A Pasi; C Badulli; I Sbarsi; A L Cremaschi; F Garlaschelli; C Pizzochero; M C Monti; C Montecucco; G R Corazza; D Larizza; P E Bianchi; L Salvaneschi; M Martinetti
Journal:  Biomed Res Int       Date:  2013-01-21       Impact factor: 3.411

10.  Ultra-high resolution HLA genotyping and allele discovery by highly multiplexed cDNA amplicon pyrosequencing.

Authors:  Simon M Lank; Brittney A Golbach; Hannah M Creager; Roger W Wiseman; Derin B Keskin; Ellis L Reinherz; Vladimir Brusic; David H O'Connor
Journal:  BMC Genomics       Date:  2012-08-06       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.